Evidence map›Paper›PMID 41986288›Full record

ArticleBritish journal of haematology2026

Distribution of adult T-cell leukaemia/lymphoma subtypes and survival outcomes across geographical regions: An international retrospective cohort study.

Bryan Valcarcel, Atae Utsunomiya, Maki Otsuka, Masaharu Miyahara, Kenji Ishitsuka, Yasushi Takamatsu, Junji Suzumiya, Kazuo Tamura, Jule F Vasquez, Daniel Enriquez-Vera and 22 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Bryan ValcarcelDepartment of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Atae UtsunomiyaDepartment of Hematology, Imamura General Hospital, Kagoshima, Japan.ORCID https://orcid.org/0000-0002-8843-406X
Maki OtsukaDepartment of Hematology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan.
Masaharu MiyaharaKaratsu Red Cross Hospital, Karatsu, Japan.
Kenji IshitsukaKagoshima University Hospital, Kagoshima, Japan.
Yasushi TakamatsuFukuoka University, Fukuoka, Japan.
Junji SuzumiyaDepartment of Hematology, Koga Community Hospital, Yaizu, Japan.
Kazuo TamuraFukuoka University, Fukuoka, Japan.
Jule F VasquezInstituto Nacional de Enfermedades Neoplasicas, Lima, Peru.
Daniel Enriquez-VeraEscuela Profesional de Medicina Humana, Universidad Privada San Juan Bautista, Lima, Peru.
Brady E BeltranFacultad de Ciencias de la Salud, Universidad San Ignacio de Loyola, Lima, Peru.
Denisse CastroFacultad de Ciencias de la Salud, Universidad San Ignacio de Loyola, Lima, Peru.
Thanya RuncimanServicio de Oncología Medica, Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru.
Henry IdroboClinical Central del Eje, Pereira, Colombia.
Elizabeth ArrietaFundación Valle del Lili, Cali, Colombia.
Oriana AriasFundación Valle del Lili, Cali, Colombia.
Eduardo GotuzzoUniversidad Peruana Cayetano Heredia, Instituto de Medicina Tropical Alexander von Humboldt, Lima, Peru.
Gabriela Garrido-PinzásUniversidad Peruana Cayetano Heredia, Instituto de Medicina Tropical Alexander von Humboldt, Lima, Peru.
Victor RiveraHospital Nacional Cayetano Heredia, San Martín de Porres, Peru.
Daniel La RosaHospital Nacional Cayetano Heredia, San Martín de Porres, Peru.
Camila PeñaHospital Del Salvador, Santiago, Chile.
Lorena FiadHematología, Hospital Italiano de La Plata, La Plata, Argentina.
Juan C RamosUniversity of Miami, Miami, Florida, USA.
Jose Sandoval-SusMoffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System, Memorial Cancer Institute, Pembroke Pines, Florida, USA.
Alejandro SicaDepartment of Oncology, Montefiore Medical Center, Bronx, New York, USA.
Britney N BellBoston University Chobanian & Avedisian School of Medicine, Boston University Center for Forced Displacement, Boston, Massachusetts, USA.
Lucy B CookDepartment of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.
Veronica LeataudDepartment of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Eliana C M MirandaUniversidade Estadual de Campinas - UNICAMP, Hemocentro, Sao Paulo, Brazil.ORCID https://orcid.org/0000-0002-7177-7664
Carlos ChiattoneSanta Casa Medical School, Sao Paulo, Brazil.
Hiroo KatsuyaSaga University, Saga, Japan.
Luis MalpicaDepartment of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Funding

Amos Medical Faculty Development Program from the American Society of HematologyBirdies Fore Logan FoundationRobert A. Winn Diversity in Clinical Trials
6 · The paper itself

Abstract

Although adult T-cell leukaemia/lymphoma (ATL) has a higher burden in certain world regions, outcomes have not been directly compared across regions. We conducted a multicentre cohort study comparing the distribution of ATL subtypes and overall survival (OS) across 1090 adults (≥18 years) diagnosed with ATL during 2000-2023 in Japan (n = 366), South America (n = 364), the United States (n = 275) and the United Kingdom (n = 85). Survival was estimated using Kaplan-Meier methods. Acute ATL was more frequent in Japan (59%) than in the United States (45%), South America (36%) and the United Kingdom (24%) (p

Indexed as

Leukemia-Lymphoma, Adult T-CellAdultAgedFemaleHumansJapanMaleMiddle AgedRetrospective StudiesSouth AmericaUnited KingdomUnited Statesadult T‐cell leukaemia/lymphomaepidemiologyHTLV‐1prevalencesurvival

Identifiers

PMID41986288
PMCPMC13340507

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.